Trials / Completed
CompletedNCT00720694
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
Placebo Controlled Study to Investigate the Effectiveness and Safety of Extracorporeal Shock Wave Therapy in Unsuccessful Conservatively Treated Subject Suffering From Painful Heel Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Storz Medical AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Duolith SD1 | |
| DEVICE | Sham Duolith SD1 |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-05-01
- First posted
- 2008-07-23
- Last updated
- 2018-02-19
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT00720694. Inclusion in this directory is not an endorsement.